Month: April 2026

MONTREAL, April 15, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to present a corporate update at the 2026 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 21, 2026, at 2:00 p.m. ET at the Metro Toronto Convention Centre (North Building) in Toronto. A copy of the presentation will be available at www.knighttx.com. About Knight Therapeutics Inc. Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight’s Latin American subsidiaries operate under United Medical, Biotoscana Farma and...

Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran WARMINSTER, Pa., April 15, 2026 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation for imdusiran for the treatment of chronic hepatitis B (“cHBV”). “We are excited about the potential of imdusiran, which in trials has achieved functional cure for 10 chronic hepatitis B patients to date and allowed many others to live medication-free, to address significant unmet medical need,” said Lindsay Androski, President and CEO of Arbutus. “The FDA grant of Fast Track designation validates imdusiran as an important drug...

Not for distribution to United States newswire services or for dissemination in the United States TORONTO, April 15, 2026 (GLOBE NEWSWIRE) — Black Iron Inc. (TSX:BKI) (“Black Iron” or the “Company”) announces that due to strong investor demand, it has upsized the listed issuer financing exemption offering previously announced on April 6, 2026 by US$200,000, from gross proceeds of up to US$1,700,000 (C$2,366,060) to gross proceeds of up to US$1,900,000 (C$2,626,750) (the “LIFE Offering”). The LIFE Offering continues to be conducted on a non-brokered basis at a price of $0.10 per unit of the Company (each, a “Unit”), for the issuance of up to an additional 2,606,900 Units pursuant to the upsizing, bringing the maximum number of Units issuable under the LIFE Offering to 26,267,500 Units if fully subscribed. Each Unit will consist of...

Growing payer acceptance of nurse practitioner administration of Deep TMS is expected to expand access to non‑drug mental health treatments BURLINGTON, Mass. and JERUSALEM, April 15, 2026 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today highlighted the growing trend across the U.S. payer landscape of coverage policies that allow appropriately trained nurse practitioners to administer Transcranial Magnetic Stimulation (TMS) therapy. A growing number of commercial insurers, Medicare Administrative Contractors (MACs), and government payers now permit psychiatric mental health nurse practitioners (PMHNPs) to administer TMS therapy, including Deep TMS™, when practicing in accordance...

DALLAS, April 15, 2026 (GLOBE NEWSWIRE) — Ridgepost Capital, Inc. (NYSE: RPC) (“Ridgepost Capital” or the “Company”), a leading private markets solutions provider, today announced it will release its first quarter 2026 results on Thursday, May 7, 2026, before U.S. markets open. The Company will host an earnings conference call at 8:30 a.m. Eastern Time on May 7, 2026. The webcast may be accessed here. All participants joining by telephone should register here for personal dial-in and PIN numbers. For those unable to participate in the live call, a replay will be made available on the Company’s investor relations page. About Ridgepost CapitalRidgepost Capital (NYSE: RPC) is a leading private markets solutions provider with over $43 billion in assets under management as of December 31, 2025. Ridgepost Capital invests across Private...

Vancouver, BC, April 15, 2026 (GLOBE NEWSWIRE) — Deep Sea Minerals Corp. (CSE: SEAS) (OTCQB: DSEAF) (FSE: X450) (“Deep Sea Minerals” or the “Company”), a subsea mineral exploration and development company focused on advancing critical mineral opportunities from the deep ocean, is pleased to announce the appointment of Anthony Zelen to its Board of Directors, effective immediately. The Company also announces that Barry Greene will be stepping down from the Board. Mr. Zelen is a seasoned entrepreneur with over 30 years of experience in the public markets, bringing extensive expertise in finance, investor relations, sales, and corporate development. He is the co-founder of Mindshare Communications Inc. and Senergy Communications Capital Inc., both of which specialized in investor and public relations, social...

WILMINGTON, Del., April 15, 2026 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude Therapeutics” or the “Company”), a clinical-stage precision oncology company, today announced that Dr. Charles Morris will join the Company as Chief Medical Officer effective, April 20, 2026. “We are thrilled to welcome Dr. Charles Morris to Prelude Therapeutics as Executive Vice President and Chief Medical Officer,” stated Kris Vaddi, Chief Executive Officer of Prelude Therapeutics. “With our two lead programs targeting myeloproliferative neoplasms and ER+ breast cancer advancing expected to enter into clinical development in 2026, Dr. Morris’s deep clinical experience, track record of developing successful oncology medicines and proven leadership will be instrumental in ensuring we execute these programs with both rigor...

Boca Raton, FL, April 15, 2026 (GLOBE NEWSWIRE) — Powell Max Limited (Nasdaq: PMAX) (“Powell Max” or the “Company”), a financial communications services provider, today announced a 1-for-10 share consolidation (the “Share Consolidation”) of all issued and outstanding ordinary shares, effective at the opening of trading on April 17, 2026. The Share Consolidation is intended to increase the market price per share of the Company’s Class A Ordinary Shares to a level above the US$1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The Share Consolidation will be effected pursuant to the Sixth Amended and Restated Memorandum and Articles of Association. The Company’s Class A Ordinary Shares (the “Class A Ordinary Shares”) will continue to trade on the Nasdaq Capital Market under the ticker symbol “PMAX”...

Phase 3 trial evaluated two subcutaneous BRIUMVI dosing regimens; administration every 2 months or every 3 months Top-line data expected year-end 2026/ first quarter 2027 NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), announced the completion of enrollment in a Phase 3 trial evaluating subcutaneous BRIUMVI (ublituximab-xiiy), the Company’s anti-CD20 monoclonal antibody, in people with relapsing forms of multiple sclerosis (RMS). BRIUMVI is currently approved in the United States and several ex-US territories as a one-hour intravenous (IV) infusion administered twice a year, following the starting dose, in adults with RMS. Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, stated, “The completion of enrollment in our Phase 3 subcutaneous BRIUMVI trial represents a significant...

Monthly Highlights Bitcoin: Production increased 480% Y/Y to 661 Bitcoin SEALMINERs: SEALMINER A4 series officially launched with efficiency reaches to ~9.45 J/T Colocation: Continued management focus on colocation lease agreements, with Tydal, Norway site in negotiations AI Cloud: Demonstrating strong M/M performance in ARR and utilization ratesKey Metrics SummaryGlobal EnergyCapacity Self-MiningHash Rate Self-OwnedRigs BTCMined AI CloudARR Colocation AI Data Center3.0 GW 69.5 (EH/s) 225K 661 ~$43M Tydal, Norway in negotiations           SINGAPORE, April 15, 2026 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for AI and Bitcoin mining infrastructure, today announced its unaudited operations updates for March 2026. Management...